847 related articles for article (PubMed ID: 33755656)
1. Comparison table: Some drugs for HFrEF.
Med Lett Drugs Ther; 2021 Mar; 63(1619):e1-e13. PubMed ID: 33755656
[No Abstract] [Full Text] [Related]
2. Comparison chart: Some drugs for HFrEF.
Med Lett Drugs Ther; 2021 Jun; 63(1626):e1-e14. PubMed ID: 34181629
[No Abstract] [Full Text] [Related]
3. Expanded table: Some drugs for HFrEF.
Med Lett Drugs Ther; 2019 Apr; 61(1569):e57-e62. PubMed ID: 31169798
[No Abstract] [Full Text] [Related]
4. Drugs for chronic heart failure.
Med Lett Drugs Ther; 2019 Apr; 61(1569):49-54. PubMed ID: 31169796
[No Abstract] [Full Text] [Related]
5. Drugs for chronic heart failure.
Med Lett Drugs Ther; 2021 Jun; 63(1626):89-96. PubMed ID: 34181628
[No Abstract] [Full Text] [Related]
6. Drugs for hypertension.
Med Lett Drugs Ther; 2020 May; 62(1598):73-80. PubMed ID: 32555118
[No Abstract] [Full Text] [Related]
7. Drugs for hypertension.
Med Lett Drugs Ther; 2024 May; 66(1703):81-88. PubMed ID: 38771738
[No Abstract] [Full Text] [Related]
8. Vericiguat (Verquvo) for heart failure.
Med Lett Drugs Ther; 2021 Mar; 63(1619):36-37. PubMed ID: 33755653
[No Abstract] [Full Text] [Related]
9. Update of treatment of heart failure with reduction of left ventricular ejection fraction.
Aronow WS
Arch Med Sci Atheroscler Dis; 2016; 1(1):e106-e116. PubMed ID: 28905031
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological management of chronic heart failure: old drugs, new drugs and new indications.
Lim WY; Woldman S
Br J Hosp Med (Lond); 2013 Feb; 74(2):C18-22. PubMed ID: 23411909
[No Abstract] [Full Text] [Related]
12. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
[TBL] [Abstract][Full Text] [Related]
13. Current treatment of heart failure with reduction of left ventricular ejection fraction.
Aronow WS
Expert Rev Clin Pharmacol; 2016 Dec; 9(12):1619-1631. PubMed ID: 27673415
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in the treatment of congestive heart failure.
Chen SC
Indian J Pediatr; 1998; 65(1):13-20. PubMed ID: 10771942
[TBL] [Abstract][Full Text] [Related]
15. Contemporary Drug Treatment of Chronic Heart Failure With Reduced Ejection Fraction: The CHECK-HF Registry.
Brunner-La Rocca HP; Linssen GC; Smeele FJ; van Drimmelen AA; Schaafsma HJ; Westendorp PH; Rademaker PC; van de Kamp HJ; Hoes AW; Brugts JJ;
JACC Heart Fail; 2019 Jan; 7(1):13-21. PubMed ID: 30606482
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations.
Klein L; O'Connor CM; Gattis WA; Zampino M; de Luca L; Vitarelli A; Fedele F; Gheorghiade M
Am J Cardiol; 2003 May; 91(9A):18F-40F. PubMed ID: 12729848
[TBL] [Abstract][Full Text] [Related]
17. Drug-patient interactions and their relevance in the treatment of heart failure.
Johnston D; Duffin D
Am J Cardiol; 1992 Oct; 70(10):109C-112C. PubMed ID: 1329465
[TBL] [Abstract][Full Text] [Related]
18. Treatment of heart failure with normal left ventricular ejection fraction.
Aronow WS
Compr Ther; 2007; 33(4):223-30. PubMed ID: 18025614
[TBL] [Abstract][Full Text] [Related]
19. Effect of Combining Ivabradine and β-Blockers: Focus on the Use of Carvedilol in the SHIFT Population.
Bocchi EA; Böhm M; Borer JS; Ford I; Komajda M; Swedberg K; Tavazzi L;
Cardiology; 2015; 131(4):218-24. PubMed ID: 25968495
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
